Using AI to Improve COPD Care Guidelines
Using Large Language Models Such As GPT-4 to Assess Guideline Adherence in Patients with Chronic Obstructive Pulmonary Disease
This study is testing if using AI can help doctors follow better guidelines for treating COPD to improve care and reduce hospital visits for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin) |
| Trial ID | NCT06410547 on ClinicalTrials.gov |
What this trial studies
This study aims to utilize large language models, such as GPT-4, to evaluate and enhance adherence to clinical guidelines in the management of Chronic Obstructive Pulmonary Disease (COPD). By analyzing patient data and treatment plans, the study seeks to identify gaps in guideline adherence that may lead to exacerbations and hospitalizations. The approach involves a prospective, randomized trial design to assess the effectiveness of AI in improving patient outcomes and ensuring evidence-based care is implemented in clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with COPD who have recently been discharged from hospitalization and are able to provide consent.
Not a fit: Patients who lack the capacity to provide consent or those who do not have a diagnosis of COPD will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of COPD, reducing exacerbations and hospitalizations for patients.
How similar studies have performed: While the use of AI in healthcare is a growing field, this specific application of large language models for guideline adherence in COPD is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of COPD * Consent * Discharge after hospitalization Exclusion Criteria: * Lack of Consent
Where this trial is running
Berlin
- Charité University — Berlin, Germany (Recruiting)
Study contacts
- Principal investigator: Matthias Gröschel, MD PhD — Charité
- Study coordinator: Matthias Gröschel, MD PhD
- Email: matthias.groeschel@charite.de
- Phone: +4915906714937
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.